Biomakers: Democratizing access to precision medicine to low-Income cancer patients
Provide access to molecular profiling for oncology patients in LAC, with special focus on women and patients from public healthcare systems.

Project Detail

Country

Regional

Project Number

RG-Q0151

Approval Date

November 20, 2025

Project Status

Implementation

Project Type

Equity

Sector

SOCIAL INVESTMENT

Subsector

HUMAN RESOURCES & WORKFORCE DEVELOPMENT

Lending Instrument

Multilateral Investment Fund Instrument

Lending Instrument Code

MIF

Modality

-

Facility Type

-

Environmental and Social Impact Category (ESIC)

-

Total Cost

USD 8,500,000.00

Country Counterpart Financing

USD 7,000,000.00

Original Amount Approved

USD 1,500,000.00
Financial Information
Operation Number Lending Type Reporting Currency Reporting Date Signed Date Fund Financial Instrument
EQU/MS-22151-RG Non-Sovereign Guaranteed USD - United States Dollar MIF-Small Enterprise Investment Fund
Operation Number EQU/MS-22151-RG
  • Lending Type: Non-Sovereign Guaranteed
  • Reporting Currency: USD - United States Dollar
  • Reporting Date:
  • Signed Date:
  • Fund: MIF-Small Enterprise Investment Fund
  • Financial Instrument:

Can’t find a document? Request information

 Implementation Phase
https://www.iadb.org/document.cfm?id=EZIDB000358-1798926200-5
Donors Memorandum
RG-Q0151 Executive Summary.pdf
Feb. 25, 2026
English
https://www.iadb.org/document.cfm?id=EZIDB000358-1798926200-6
Donors Memorandum
RG-Q0151 Resumen Ejecutivo.pdf
Feb. 25, 2026
Spanish

Have an Environmental or Social issue related to IDB projects? File a Complaint